Similar articles for PMID: 28705916

Year	Number of Results
1998	1
2002	1
2003	1
2007	2
2008	2
2009	2
2010	2
2011	3
2012	6
2013	8
2014	5
2015	5
2016	6
2017	8
2018	12
2019	17
2020	16
2021	16
2022	14
2023	11
2024	0

1

Biodistribution and Dosimetry of ¹⁸F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.

Pandit-Taskar N, Zanzonico P, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko S, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Pandit-Taskar N, et al. J Nucl Med. 2018 Jan;59(1):147-153. doi: 10.2967/jnumed.117.193169. Epub 2017 Jul 13. J Nucl Med. 2018. PMID: 28705916 Free PMC article. Clinical Trial.

2

[¹⁸F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [¹²³I] MIBG in neural crest tumour patients.

Pauwels E, Celen S, Baete K, Koole M, Bechter O, Bex M, Renard M, Clement PM, Jentjens S, Serdons K, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1134-1145. doi: 10.1007/s00259-022-06046-7. Epub 2022 Nov 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 36435928

3

[¹⁸F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study.

Samim A, Blom T, Poot AJ, Windhorst AD, Fiocco M, Tolboom N, Braat AJAT, Viol SLM, van Rooij R, van Noesel MM, Lam MGEH, Tytgat GAM, de Keizer B. Samim A, et al. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1146-1157. doi: 10.1007/s00259-022-06063-6. Epub 2022 Dec 12. Eur J Nucl Med Mol Imaging. 2023. PMID: 36504277 Free PMC article. Clinical Trial.

4

Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.

Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Zhang H, et al. Clin Cancer Res. 2014 Apr 15;20(8):2182-91. doi: 10.1158/1078-0432.CCR-13-1153. Epub 2014 Feb 26. Clin Cancer Res. 2014. PMID: 24573553 Free PMC article.

5

[¹⁸F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [⁶⁸Ga]Ga-DOTATATE in neuroendocrine tumour patients.

Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3033-3046. doi: 10.1007/s00259-020-04918-4. Epub 2020 Jul 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32617641

6

Biodistribution and radiation dose estimates for ⁶⁸Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.

Krebs S, Pandit-Taskar N, Reidy D, Beattie BJ, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, O'Donoghue JA. Krebs S, et al. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):677-685. doi: 10.1007/s00259-018-4193-y. Epub 2018 Oct 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 30374529 Free PMC article. Clinical Trial.

7

Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.

Doss M, Kolb HC, Zhang JJ, Bélanger MJ, Stubbs JB, Stabin MG, Hostetler ED, Alpaugh RK, von Mehren M, Walsh JC, Haka M, Mocharla VP, Yu JQ. Doss M, et al. J Nucl Med. 2012 May;53(5):787-95. doi: 10.2967/jnumed.111.088955. Epub 2012 Apr 12. J Nucl Med. 2012. PMID: 22499613 Free PMC article. Clinical Trial.

8

Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[¹⁸F]Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry.

Lokitz SJ, Garg S, Nazih R, Garg PK. Lokitz SJ, et al. Mol Imaging Biol. 2019 Aug;21(4):686-695. doi: 10.1007/s11307-018-1280-1. Mol Imaging Biol. 2019. PMID: 30250991

9

Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D. Nicolas GP, et al. J Nucl Med. 2018 Jun;59(6):909-914. doi: 10.2967/jnumed.117.199737. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025985 Free article. Clinical Trial.

10

Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.

Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu Z, Alpaugh RK, Lango MN, Yu JQ. Doss M, et al. J Nucl Med. 2013 Dec;54(12):2087-92. doi: 10.2967/jnumed.113.119800. Epub 2013 Oct 17. J Nucl Med. 2013. PMID: 24136934 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year